EBRO 2017

Conclusions

EBRO 2017

• Incidence of esophageal cancer is increasing

• Prognosis is poor due to advanced stages at diagnosis

• Treatment is challenging and requires multidisciplinary approach

• Largest gain is obtained in neo-adjuvant setting (CRT>CT?)